Characterization of a new compound, S35b, as a guanylate cyclase activator in human platelets
- 17 March 1992
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 43 (6) , 1281-1288
- https://doi.org/10.1016/0006-2952(92)90504-c
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cyclic GMP analogs inhibit gamma thrombin-induced arachidonic acid release in human plateletsBiochemical and Biophysical Research Communications, 1989
- Inhibitory action of cyclic AMP on inositol 1,4,5-trisphosphate-induced Ca2+ release in saponin-permeabilized plateletsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1989
- Activation of platelet phospholipase C by fluoride is inhibited by elevation of cyclic AMPBiochemical and Biophysical Research Communications, 1989
- On the Mechanism of NO Release from SydnoniminesJournal of Cardiovascular Pharmacology, 1989
- Inhibition of Calcium Influx in Thrombin-Stimulated Platelets by SIN-1, an Activator of Soluble Guanylate CyclaseJournal of Cardiovascular Pharmacology, 1989
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Inhibitory action of cyclic GMP on secretion, polyphosphoinositide hydrolysis and calcium mobilization in thrombin-stimulated human plateletsBiochemical and Biophysical Research Communications, 1986
- Regulation of platelet cytosolic free calcium by cyclic nucleotides and protein kinase CFEBS Letters, 1985
- Cytoplasmic Ca2+ in platelets is controlled by cyclic AMP: Antagonism between stimulators and inhibitors of adenylate cyclaseBiochemical and Biophysical Research Communications, 1984
- The cytoplasmic concentration of free calcium in platelets is controlled by stimulators of cyclic AMP production (PGD2, PGE1, forskolin)Biochemical and Biophysical Research Communications, 1983